IF
CRL icon

Intrua Financial’s Charles River Laboratories CRL Stock Holding History

Intrua Financial’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-984
Closed -$211K – 309
2022
Q2 		$211K Sell
984
-32
-3% -$7.82K 0.04% 340
2022
Q1 		$289K Buy
1,016
+81
+9% +$25K 0.05% 307
2021
Q4 		$352K Buy
935
+13
+1% +$5.05K 0.06% 275
2021
Q3 		$397K Buy
922
+10
+1% +$4.15K 0.07% 249
2021
Q2 		$364K Buy
912
+46
+5% +$15.4K 0.09% 203
2021
Q1 		$290K Buy
866
+19
+2% +$5.28K 0.07% 227
2020
Q4 		$212K Buy
+847
New +$202K 0.09% 195

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Intrua Financial's CRL Position: Q3 2022 in Review

Intrua Financial sold out of Charles River Laboratories (CRL) in Q3 2022, closing a stake of 984 shares — an estimated $211K sold.

Intrua Financial first reported a position in CRL in Q4 2020 and held it in 7 quarters. The position peaked at $397K in Q3 2021. 583 funds tracked by Wall St. Rank hold CRL as of Q3 2022.

  • Intrua Financial reported no remaining Charles River Laboratories position as of Q3 2022 after selling out during the quarter.
  • Intrua Financial sold 984 Charles River Laboratories shares in Q3 2022, an estimated $211K.
  • Intrua Financial first reported a position in Charles River Laboratories in Q4 2020 and held it in 7 quarters.
  • Intrua Financial's Charles River Laboratories position peaked at $397K in Q3 2021.
  • 583 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2022.

Based on Intrua Financial's 13F filing for Q3 2022, filed 14 Nov 2022.